154 related articles for article (PubMed ID: 12100110)
1. The effect of lymphatic tumor burden on sentinel lymph node biopsy results.
Wong SL; Edwards MJ; Chao C; Simpson D; McMasters KM
Breast J; 2002; 8(4):192-8. PubMed ID: 12100110
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate.
Wong SL; Edwards MJ; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Cerrito PB; McMasters KM
J Am Coll Surg; 2001 Jun; 192(6):684-9; discussion 689-91. PubMed ID: 11400961
[TBL] [Abstract][Full Text] [Related]
3. Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer.
Goyal A; Douglas-Jones AG; Newcombe RG; Mansel RE
Breast J; 2005; 11(3):188-94. PubMed ID: 15871704
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.
McMasters KM; Tuttle TM; Carlson DJ; Brown CM; Noyes RD; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Cerrito PB; Edwards MJ
J Clin Oncol; 2000 Jul; 18(13):2560-6. PubMed ID: 10893287
[TBL] [Abstract][Full Text] [Related]
5. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
6. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
9. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes.
McMasters KM; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Dirk Noyes R; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Edwards MJ
Ann Surg; 2000 May; 231(5):724-31. PubMed ID: 10767794
[TBL] [Abstract][Full Text] [Related]
10. Second echelon node predicts metastatic involvement of additional axillary nodes following sentinel node biopsy in early breast cancer.
Bassi KK; Seenu V; Ballehaninna UK; Parshad R; Chumber S; Dhar A; Gupta SD; Kumar R; Srivastava A
Indian J Cancer; 2006; 43(3):103-9. PubMed ID: 17065767
[TBL] [Abstract][Full Text] [Related]
11. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
[TBL] [Abstract][Full Text] [Related]
12. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group.
Martin RC; Edwards MJ; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Noyes RD; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Cerrito PB; McMasters KM
Surgery; 2000 Aug; 128(2):139-44. PubMed ID: 10922983
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
Dabbs DJ; Fung M; Johnson R
Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
[TBL] [Abstract][Full Text] [Related]
14. Final results of the Department of Defense multicenter breast lymphatic mapping trial.
Shivers S; Cox C; Leight G; Beauchamp D; Blumencranz P; Ross M; Reintgen D
Ann Surg Oncol; 2002 Apr; 9(3):248-55. PubMed ID: 11923131
[TBL] [Abstract][Full Text] [Related]
15. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET for axillary lymph node staging in primary breast cancer.
Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Kuwano H
Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
[TBL] [Abstract][Full Text] [Related]
20. [Sentinel node biopsy in breast cancer and primary tumor dimension].
Basta P; Tomaszewska R; Pityński K; Opławski M; Basta A
Ginekol Pol; 2003 Sep; 74(9):666-70. PubMed ID: 14674105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
